Asset Details
Do you wish to reserve the book?
Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy
Do you wish to request the book?
Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy
2025
Overview
Messenger RNA (mRNA) vaccines offer an adaptable and scalable platform for cancer immunotherapy, requiring optimal design to elicit a robust and targeted immune response. Recent advancements in bioinformatics and artificial intelligence (AI) have significantly enhanced the design, prediction, and optimization of mRNA vaccines. This paper reviews technologies that streamline mRNA vaccine development, from genomic sequencing to lipid nanoparticle (LNP) formulation. We discuss how accurate predictions of neoantigen structures guide the design of mRNA sequences that effectively target immune and cancer cells. Furthermore, we examine AI-driven approaches that optimize mRNA-LNP formulations, enhancing delivery and stability. These technological innovations not only improve vaccine design but also enhance pharmacokinetics and pharmacodynamics, offering promising avenues for personalized cancer immunotherapy.
Publisher
Frontiers Media SA,Frontiers Media S.A
Subject
/ Antigens
/ Antigens, Neoplasm - immunology
/ Cancer
/ Cancer Vaccines - immunology
/ Cellular and Infection Microbiology
/ Computational Biology - methods
/ Genomes
/ Humans
/ mRNA
/ Mutation
/ Oncology
/ Vaccine Development - methods
/ Vaccines, Synthetic - genetics
/ Vaccines, Synthetic - immunology
/ Viruses
